CFO transition
Co-Diagnostics, Inc. CFO transition: Daniel Bohrer to succeed Brian Brown
Co-Diagnostics, Inc. reported in a Form 8-K filed September 4, 2026 that Daniel Bohrer will succeed Brian Brown as principal financial officer and principal accounting officer, effective September 2, 2026.
In the filing's words
Effective as of the Separation Date, Daniel Bohrer, the Company’s Executive Vice President of Finance and Accounting, will serve as the Company’s principal financial officer and principal accounting officer.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Co-Diagnostics, Inc. (CODX) |
|---|---|
| Event | Transition |
| Incoming | Daniel Bohrer |
| Outgoing | Brian Brown |
| Title in the filing | principal financial officer and principal accounting officer |
| Effective | September 2, 2026 |
| 8-K filed | September 4, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Executive Vice President of Finance and Accounting, Co-Diagnostics, Inc. |
| SEC CIK | 0001692415 |
Co-Diagnostics, Inc. reported this change in a Form 8-K, Item 5.02, filed September 4, 2026. The filing's own words are quoted above.
Other records naming Brian Brown
1The outgoing officer on this record, matched by name. Career line.
2026-03-31 · 10-K signature
Brian Brown signed Co-Diagnostics, Inc.'s annual report as Chief Financial Officer (Principal Financial and Accounting Officer)
Same industry, September 2026
2Other moves filed that month at companies the roster files under SIC “Surgical & Medical Instruments & Apparatus”.
6 weeks ago· 2026-09-30TransitionCARL
Carlsmed, Inc. CFO transition: Richard Heppenstall to succeed Leo Greenstein
7 weeks ago· 2026-09-21TransitionCVRX
CVRx, Inc. CFO transition: John Landry to succeed Jared Oasheim
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Daniel Bohrer? Send a correction with the primary source.